<i id='8B0DF9F013'><strike id='8B0DF9F013'><tt id='8B0DF9F013'><pre id='8B0DF9F013'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
DIEP, the 'gold standard' of breast reconstruction, is under threat 
Intercept Pharmaceuticals sells itself for less than $1 billion 
Anesthesiologist group: stop taking Ozempic before surgery 
Sudafed saga points to U.S. issues with evaluating older drugs 
Peter Hotez and the public health issue of online harassment 
Study links childhood stress with decline in older age 
New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum 
How the Dana 
State Dept. review finds Biden bears some blame for Afghanistan failures 
Biotech startup Celsius cuts 75% of staff ahead of first trial start 
Hepatitis C has a cure — but many Americans still lack access to it 
H.R. 3 is the wrong path to lower drug costs 
Cancer drug shortages should be causing more outrage 
Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses 
Dobbs anniversary: the lost opportunity of abortion as health care 
